Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with …
A Tu, X Zhu, PZ Dastjerdi, Y Yin, M Peng, D Zheng… - Heliyon, 2024 - cell.com
Abstract Background Traditional Chinese Medicine (TCM), has been used for hepatocellular
carcinoma (HCC) at every therapeutic stage, even before tumor formation. However, the …
carcinoma (HCC) at every therapeutic stage, even before tumor formation. However, the …
[HTML][HTML] Molecular insights into experimental models and therapeutics for cholestasis
W Zhang, H Wu, S Luo, X Lu, X Tan, L Wen… - Biomedicine & …, 2024 - Elsevier
Cholestatic liver disease (CLD) is a range of conditions caused by the accumulation of bile
acids (BAs) or disruptions in bile flow, which can harm the liver and bile ducts. To investigate …
acids (BAs) or disruptions in bile flow, which can harm the liver and bile ducts. To investigate …
Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis
Y Li, X Deng, X Tan, Q Li, Z Yu, W Wu, X Ma… - Frontiers in …, 2024 - frontiersin.org
Background: Pathological progression from non-alcoholic fatty liver disease (NAFLD) to liver
fibrosis (LF) to hepatocellular carcinoma (HCC) is a common dynamic state in many …
fibrosis (LF) to hepatocellular carcinoma (HCC) is a common dynamic state in many …
Co-catalpol alleviates fluoxetine-induced main toxicity: Involvement of ATF3/FSP1 signaling-mediated inhibition of ferroptosis
X Wu, Y Guan, J Wang, L Song, Y Zhang, Y Wang, Y Li… - Phytomedicine, 2024 - Elsevier
Background Fluoxetine is often used as a well-known first-line antidepressant. However, it is
accompanied with hepatogenic injury as its main organ toxicity, thereby limiting its …
accompanied with hepatogenic injury as its main organ toxicity, thereby limiting its …
[HTML][HTML] Network pharmacological analysis on the mechanism of Linggui Zhugan decoction for nonalcoholic fatty liver disease
S Gao, L Wei, Y Qin, P Zhang, T Quan, F Liang… - Medicine, 2024 - journals.lww.com
Nonalcoholic fatty liver disease (NAFLD), represents a chronic progressive disease that
imposes a significant burden on patients and the healthcare system. Linggui Zhugan …
imposes a significant burden on patients and the healthcare system. Linggui Zhugan …
Liver protein and metabolite biolabels reveal hepatoprotective effects and active compounds of Eucommiae folium: Exploration of new application of herb based on …
SN Zhang, Q Liu, XZ Li, WD Yang, Y Zhou - Journal of Pharmaceutical and …, 2024 - Elsevier
A biolabel-led research based on multi-omics and bioinformatics was applied to analyze the
application value of Eucommiae folium (EF) in liver cirrhosis, as well as the mechanism of …
application value of Eucommiae folium (EF) in liver cirrhosis, as well as the mechanism of …